110 related articles for article (PubMed ID: 15119287)
1. Immune strategy.
Proj Inf Perspect; 2004 Jan; (37):21-3. PubMed ID: 15119287
[TBL] [Abstract][Full Text] [Related]
2. HIV and the cells it infects: sorting the latent from the labile. An interview with Mike McCune, MD, PhD. Interview by Mark Mascolini.
McCune JM
J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):20-2, 25-7, 41. PubMed ID: 11363326
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.
Beq S; Delfraissy JF; Theze J
Eur Cytokine Netw; 2004; 15(4):279-89. PubMed ID: 15627636
[TBL] [Abstract][Full Text] [Related]
4. Will immune-based therapies ever be approved?
Lein B
Res Initiat Treat Action; 2002; 8(1):26-9. PubMed ID: 12489524
[No Abstract] [Full Text] [Related]
5. Gene therapy: beating HIV at its own game.
Servilio J
Posit Aware; 1995; VI(6):22-4. PubMed ID: 11363145
[TBL] [Abstract][Full Text] [Related]
6. Immune-based therapies in brief.
Proj Inf Perspect; 2000 Mar; (29):19-20. PubMed ID: 12772669
[TBL] [Abstract][Full Text] [Related]
7. Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.
Barbour JD; Hecht FM; Wrin T; Segal MR; Ramstead CA; Liegler TJ; Busch MP; Petropoulos CJ; Hellmann NS; Kahn JO; Grant RM
J Infect Dis; 2004 Jul; 190(2):251-6. PubMed ID: 15216458
[TBL] [Abstract][Full Text] [Related]
8. Virology. Moving forward in HIV vaccine development.
Letvin NL
Science; 2009 Nov; 326(5957):1196-8. PubMed ID: 19965456
[No Abstract] [Full Text] [Related]
9. Managing HIV. Part 3. Mechanisms of disease. 3.2 How HIV produces immune deficiency.
Ffrench R; Stewart GJ; Penny R; Levy JA
Med J Aust; 1996 Feb; 164(3):166-71. PubMed ID: 8628137
[TBL] [Abstract][Full Text] [Related]
10. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J
Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
[TBL] [Abstract][Full Text] [Related]
11. Report from the Seventh Immune Restoration Think Tank.
Proj Inf Perspect; 1998 Sep; (25):23-4. PubMed ID: 11365848
[TBL] [Abstract][Full Text] [Related]
12. Novel HIV strategies previewed.
Smart T
GMHC Treat Issues; 1996 Dec; 10(12):6-7. PubMed ID: 11364018
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
14. Immunology. Study says HIV blood levels don't predict immune decline.
Cohen J
Science; 2006 Sep; 313(5795):1868. PubMed ID: 17008495
[No Abstract] [Full Text] [Related]
15. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
16. Mutation and control of the human immunodeficiency virus.
Stengel RF
Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629
[TBL] [Abstract][Full Text] [Related]
17. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
Aiuti F; Mezzaroma I
AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
[TBL] [Abstract][Full Text] [Related]
18. A new approach: immune-based treatments against HIV.
Berger DS
Posit Aware; 2007; 18(3):43-4. PubMed ID: 17526118
[No Abstract] [Full Text] [Related]
19. Rationale for immune-based therapies for human immunodeficiency virus type 1 infection.
Lederman MM; Valdez H
AIDS Clin Rev; 2000-2001; ():229-61. PubMed ID: 10999222
[No Abstract] [Full Text] [Related]
20. Cellular immunotherapy for cytomegalovirus and HIV-1 infection.
Van den Bosch GA; Ponsaerts P; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(2):107-21. PubMed ID: 16531812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
